These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 2543912

  • 21. Regulation of phosphoinositide turnover in neonatal rat cerebral cortex by group I- and II- selective metabotropic glutamate receptor agonists.
    Mistry R, Golding N, Challiss RA.
    Br J Pharmacol; 1998 Feb; 123(3):581-9. PubMed ID: 9504400
    [Abstract] [Full Text] [Related]

  • 22. Chronic dosing with 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, modulates NMDA inhibition of muscarinic-coupled PI hydrolysis in rat cortical slices.
    Boje KM, Lakhman SS.
    Neurochem Res; 1998 Sep; 23(9):1167-74. PubMed ID: 9712186
    [Abstract] [Full Text] [Related]

  • 23. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
    Carter C, Benavides J, Legendre P, Vincent JD, Noel F, Thuret F, Lloyd KG, Arbilla S, Zivkovic B, MacKenzie ET.
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
    [Abstract] [Full Text] [Related]

  • 24. Modulation of muscarinic cholinoceptor-stimulated inositol 1,4,5-trisphosphate accumulation by N-methyl-D-aspartate in neonatal rat cerebral cortex.
    Challis RA, Mistry R, Gray DW, Nahorski SR.
    Neuropharmacology; 1994 Jan; 33(1):15-25. PubMed ID: 7910385
    [Abstract] [Full Text] [Related]

  • 25. Interaction of 6-cyano-7-nitroquinoxaline-2,3-dione with the N-methyl-D-aspartate receptor-associated glycine binding site.
    Lester RA, Quarum ML, Parker JD, Weber E, Jahr CE.
    Mol Pharmacol; 1989 May; 35(5):565-70. PubMed ID: 2566902
    [Abstract] [Full Text] [Related]

  • 26. Selectivity of quinoxalines and kynurenines as antagonists of the glycine site on N-methyl-D-aspartate receptors.
    Kleckner NW, Dingledine R.
    Mol Pharmacol; 1989 Sep; 36(3):430-6. PubMed ID: 2550776
    [Abstract] [Full Text] [Related]

  • 27. Interaction of short chain aliphatic alcohols with muscarinic receptor-stimulated phosphoinositide metabolism in cerebral cortex from neonatal and adult rats.
    Candura SM, Balduini W, Costa LG.
    Neurotoxicology; 1991 Sep; 12(1):23-32. PubMed ID: 1849621
    [Abstract] [Full Text] [Related]

  • 28. Modulation of NMDA effects on agonist-stimulated phosphoinositide turnover by memantine in neonatal rat cerebral cortex.
    Mistry R, Wilke R, Challiss RA.
    Br J Pharmacol; 1995 Feb; 114(4):797-804. PubMed ID: 7773540
    [Abstract] [Full Text] [Related]

  • 29. Phencyclidine analogues inhibit NMDA-stimulated [3H]GABA release from cultured cortex neurons.
    Drejer J, Honoré T.
    Eur J Pharmacol; 1987 Nov 10; 143(2):287-90. PubMed ID: 3319651
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of rat brain glutamate receptors by philanthotoxin.
    Ragsdale D, Gant DB, Anis NA, Eldefrawi AT, Eldefrawi ME, Konno K, Miledi R.
    J Pharmacol Exp Ther; 1989 Oct 10; 251(1):156-63. PubMed ID: 2571715
    [Abstract] [Full Text] [Related]

  • 31. Stereoselectivity and mode of inhibition of phosphoinositide-coupled excitatory amino acid receptors by 2-amino-3-phosphonopropionic acid.
    Schoepp DD, Johnson BG, Smith EC, McQuaid LA.
    Mol Pharmacol; 1990 Aug 10; 38(2):222-8. PubMed ID: 2166902
    [Abstract] [Full Text] [Related]

  • 32. Linkage between phencyclidine (PCP) and N-methyl-D-aspartate (NMDA) receptors in the cerebellum.
    Yi SJ, Snell LD, Johnson KM.
    Brain Res; 1988 Mar 29; 445(1):147-51. PubMed ID: 2835121
    [Abstract] [Full Text] [Related]

  • 33. N-methyl-D-aspartate/glycine and quisqualate/kainate receptors expressed in Xenopus oocytes: antagonist pharmacology.
    Verdoorn TA, Kleckner NW, Dingledine R.
    Mol Pharmacol; 1989 Mar 29; 35(3):360-8. PubMed ID: 2564633
    [Abstract] [Full Text] [Related]

  • 34. Noncompetitive N-methyl-D-aspartate antagonists affect multiple ionic currents.
    Rothman S.
    J Pharmacol Exp Ther; 1988 Jul 29; 246(1):137-42. PubMed ID: 2455788
    [Abstract] [Full Text] [Related]

  • 35. Histamine-stimulated phosphoinositide hydrolysis in developing rat brain.
    Claro E, García A, Picatoste F.
    Mol Pharmacol; 1987 Sep 29; 32(3):384-90. PubMed ID: 2823091
    [Abstract] [Full Text] [Related]

  • 36. N-methyl-D-aspartate mediated responses decrease with age in Fischer 344 rat brain.
    Gonzales RA, Brown LM, Jones TW, Trent RD, Westbrook SL, Leslie SW.
    Neurobiol Aging; 1991 Sep 29; 12(3):219-25. PubMed ID: 1678878
    [Abstract] [Full Text] [Related]

  • 37. Studies of muscarinic receptor reserve linked to phosphoinositide hydrolysis in parotid gland and cerebral cortex.
    Ek B, Antonsson BM.
    Acta Physiol Scand; 1993 Mar 29; 147(3):289-95. PubMed ID: 8386426
    [Abstract] [Full Text] [Related]

  • 38. [3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes.
    Wong EH, Knight AR, Woodruff GN.
    J Neurochem; 1988 Jan 29; 50(1):274-81. PubMed ID: 2826686
    [Abstract] [Full Text] [Related]

  • 39. Pharmacology of N-methyl-D-aspartate-induced brain injury in an in vivo perinatal rat model.
    McDonald JW, Johnston MV.
    Synapse; 1990 Jan 29; 6(2):179-88. PubMed ID: 1978420
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of muscarinic-coupled phosphoinositide hydrolysis by N-methyl-D-aspartate is dependent on depolarization via channel activation.
    Morrisett RA, Chow CC, Sakaguchi T, Shin C, McNamara JO.
    J Neurochem; 1990 May 29; 54(5):1517-25. PubMed ID: 1691275
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.